Chronic myeloid leukaemia (CML) incidence statistics
Chronic myeloid leukaemia incidence by gender and UK country
| Chronic myeloid leukaemia accounts for less than 1% of all new cancer cases in the UK, with around 380 new cases in females and around 470 new cases in males every year (2017-2019). |
Chronic myeloid leukaemia incidence by age
| Incidence rates for chronic myeloid leukaemia are highest in people aged 90+ in the UK, with almost 5 in 100 (3%) of all new chronic myeloid leukaemia cases diagnosed in this age group (2017-2019). |
Chronic myeloid leukaemia incidence trends over time
| Chronic myeloid leukaemia incidence rates have decreased by around a quarter (26%) in the UK since the early 1990s and rates have increased by around a tenth (9%) in the last decade (2017-2019). |
Chronic myeloid leukaemia incidence rates (European age-standardised (AS) rates) in England in females are similar in the most deprived quintile compared with the least, and in males are similar in the most deprived quintile compared with the least (2013-2017).[1]
See also
Data table: Cancer incidence rates and excess cases by cancer type in England
Incidence by deprivation for all cancer types combined
Cancer incidence by deprivation for Scotland
Cancer incidence by deprivation for Wales
Cancer incidence by deprivation for Northern Ireland
References
- Calculated by the Cancer Intelligence Team at Cancer Research UK, April 2020. Based on method reported in National Cancer Intelligence Network Cancer by Deprivation in England Incidence, 1996-2010 Mortality, 1997-2011. Using cancer incidence data 2013-2017 (Public Health England) and population data 2013-2017 (Office for National Statistics) by Indices of Multiple Deprivation 2015 income domain quintile, cancer type, sex, and five-year age band.
About this data
Data is for England, 2013-2017, ICD-10 C92.1.
Last reviewed: 30 September 2020
More leukaemia statistics for all subtypes combined
View statistics for all leukaemia types
Statistics by cancer type
View our latest cancer statistics including key stats, in-depth explanations and raw data on cancer incidence, mortality, survival, risk, and diagnosis and treatment.
Citation
You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:
Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.
When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, 2 Redman Place, London, E20 1JQ or
Newsletter
Stay up to date by signing up to our cancer statistics and intelligence newsletter
Acknowledgements
We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.